Colorectal cancer trials in Austria

In Austria 21 Also abroad 1930

21 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Where
Salzburg, Vienna, Wiener Neustadt
Age
18 years and over
People
1,020 worldwide
Run by
EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07549412 · EU 2025-524648-37-00
No phaseTaking people
Prospective Multicenter Cohort Study of Clinical and Molecular Biomarkers in Colorectal Cancer
Where
Bregenz, Feldkirch, Hohenems, Rankweil
Age
18 years and over
People
200
Run by
Vorarlberg Institute for Vascular Investigation and Treatment
See details and how to joinNCT07913802
Phase 1/2Taking people
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Where
Linz
Age
18 years and over
People
160 worldwide
Run by
Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Where
Graz, Linz, Salzburg, Vienna
Age
18 years and over
People
700 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07284849 · EU 2025-523735-19-00
No phaseTaking people
ABCSG R07 Rectal Cancer Registry
Where
Graz, Innsbruck, Linz, Salzburg, Wiener Neustadt
Age
18 years and over
People
600
Run by
Austrian Breast & Colorectal Cancer Study Group
See details and how to joinNCT07780305
Phase 2Taking people
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Where
Graz, Salzburg, Vienna
Age
18 years and over
People
390 worldwide
Run by
AbbVie
See details and how to joinNCT06820463 · EU 2024-512981-33-00
Phase 3Not yet taking people in Austria
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.
Where
Linz, Salzburg
Age
18 years and over
People
450 worldwide
Run by
Genmab A/S
See details and how to join2026-525883-17-00 · EU 2026-525883-17-00
Phase 2/3Taking people
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Where
Feldkirch, Linz, Salzburg, St. Poelten, Vienna
Age
18 years and over
People
990 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07221357 · EU 2025-523224-45-00
Phase 1Taking people
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Where
Graz, Vienna
Age
18 years and over
People
1,394 worldwide
Run by
Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00
Phase 3Taking people
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Where
Graz, Linz, Rankweil, Vienna, Wiener Neustadt
Age
18 years and over
People
450 worldwide
Run by
Amgen
See details and how to joinNCT06252649
Phase 3Taking people
Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)
Where
Feldkirch, Graz, Linz, Vienna, Wiener Neustadt
Age
18 years to 64 years
People
241 worldwide
Run by
Amgen Inc.
See details and how to join2022-502352-31-00 · EU 2022-502352-31-00
Phase 3Taking people
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Where
Salzburg, Vienna, Wels, Wiener Neustadt
Age
18 years and over
People
400 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05253651 · EU 2024-514180-25-00
Phase 2Taking people
– IKF/AIO-QUINTIS – A Randomized Phase II Trial Evaluating Fruquintinib in Combination with Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer without Active Liver Metastases
Where
Linz, Salzburg, Wiener Neustadt
Age
18 years and over
People
140 worldwide
Run by
Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
See details and how to join2024-519929-38-00 · EU 2024-519929-38-00
No phaseTaking people
GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer
Where
Graz
Age
18 years and over
People
590 worldwide
Run by
Claus Lindbjerg Andersen
See details and how to joinNCT06111105
No phaseTaking people
Anastomotic Bleeding in Colorectal Anastomosis Relating to the Placement of the Stapler Spike to the Staple Line
Where
Linz
People
102
Run by
Kepler University Hospital
See details and how to joinNCT07506005
Phase 2Taking people
- IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases
Where
Linz, Salzburg, Wiener Neustadt
Age
18 years and over
People
140 worldwide
Run by
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
See details and how to joinNCT06856837
No phaseTaking people
AGMT Metastatic Colorectal Cancer Registry (mCRC) Third Line and Beyond
Where
Linz, Rankweil, Salzburg, Steyr, Wels, Zams
Age
18 years and over
People
500
Run by
Arbeitsgemeinschaft medikamentoese Tumortherapie
See details and how to joinNCT06678919
No phaseTaking people
The DRAGON 2 Trial
Where
Vienna
Age
18 years and over
People
348 worldwide
Run by
Maastricht University
See details and how to joinNCT05428735
No phaseTaking people
Establishment of a Tumor Bank for Blood Samples
Where
Innsbruck
Age
18 years and over
People
10,000 worldwide
Run by
Medical University of Vienna
See details and how to joinNCT01763125
No phaseTaking people
Establishment of a Tumor Bank for Tissue Samples
Where
Vienna
Age
18 years and over
People
10,000 worldwide
Run by
Medical University of Vienna
See details and how to joinNCT01789229
No phaseTaking people
BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
Where
Braunau am Inn, Feldkirch, Linz, Vienna
Age
18 years and over
People
500 worldwide
Run by
Pierre Fabre Pharma GmbH
See details and how to joinNCT04673955